This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
(MedPage Today) -- GLP-1 receptor agonists lowered the risk of several obesity-associated cancers, a retrospective analysis of electronic health records suggested. Compared with insulin, GLP-1s were associated with a lower risk for developing.
For over 50 years, rates of those who are overweight or obese have been rising rapidly. Despite the rise in obesity rates, the growing recognition of it as a global problem and the astronomical sums of money we spend on addressing it, the tide continues to rise. That is until now.
Obesity is one of the world’s biggest health crisis and only seems to be getting worse. For over 50 years, the rates of obesity have continued to rise worldwide 1. The most recent data on obesity has shown a decline for the first time in a very long time. Between 2020 and 2023, the rates of obesity dropped by about 2% 2.
A UCLA-led research team has found that a gene mutation that affects insulin signaling in the heart may raise the risk of deadly abnormal heart rhythms in a subset of patients with cancer and could have implications for those with diabetes and obesity.
These circadian mechanisms represent potential pathophysiological pathways linking circadian disruption to adverse metabolic health outcomes, including obesity, metabolic syndrome, and type 2 diabetes.
It has been shown that patients with cancer have a longer expected life duration, benefiting from advanced medical therapy. A growing number of studies have elucidated the association between cancer and CVD. Moreover, different types of cancer have distinct risks, which may increase the complexity of antithrombotic therapy.
More than heart disease or cancer, the risk of dementia often creates much greater anxiety in the patients I see. Diabetes & Insulin Resistance Type 2 diabetes is when insulin resistance reaches the point where blood sugar levels can no longer be kept in range. But can dementia be prevented? The answer is yes.
That’s what the field of obesity therapeutics feels like right now. Many pharmacies ran out of stock, and access was often restricted to keep available supplies for diabetics where the drug class had originally been developed. Subscribe now 1 [link] 2 [link] 3 Retatrutide Phase 2 Obesity Trial Investigators. N Engl J Med.
BackgroundCardiotoxicity in patients with cancer treated with anthracyclines is associated with increased morbidity and mortality. Hypertension, diabetes, hyperlipidemia, obesity, and low socioeconomic status were more common in NH Black and Hispanic individuals. Journal of the American Heart Association, Ahead of Print.
Similar patterns have been observed for cardiovascular disease and also cancer. More steps are linked to: Less obesity. Less diabetes. occupation-related physical activity and their associations with obesity. Taking 12,000-a-day steps led to a 65% reduction 5. The relationship is clear. More movement. Longer life.
The throng of epidemiological evidence hasn’t helped either — one week “butter is back” and the next, red meat is giving us diabetes. These gene-nutrient interactions influence things like the microbiome and gene expression, thereby influencing our risk for diseases like obesity, diabetes, and cardiovascular disease.
Unhealthy lifestyle habits, genetics, obesity, and other risk factors can contribute to cardiac disease at any stage of life. It affects more women than all types of cancer combined. While it is true that the risk of cardiovascular disease increases with age, it can strike people of all ages, including young adults and even children.
The throng of epidemiological evidence hasn’t helped either — one week “butter is back” and the next, red meat is giving us diabetes. These gene-nutrient interactions influence things like the microbiome and gene expression, thereby influencing our risk for diseases like obesity, diabetes, and cardiovascular disease.
That appears to be somewhat true—LaKe administration suppressed free fatty acids (FFAs) and elevated the appetite-suppressing compound N-L-lactoyl-phenylalanine (Lac-Phe), which has potential applications in obesity treatment. Importantly, the compound appeared well-tolerated, even at high doses, with no signs of toxicity in rats.
Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.
Research has linked circadian rhythm disruptions to a wide range of health issues, including cardiovascular disease, diabetes, obesity, and even certain cancers. Light is the key regulator of circadian rhythms, acting as the primary external cue, or zeitgeber, that helps our biological clocks stay on time.
And that’s exactly when obesity began a meteoric rise. Another study found that they don’t get diabetes and kidney diseases (the ninth leading cause of death). Even cancer is rare. But the food industry started leveraging it with the rise of ultraprocessed snack foods in the 1970s.
Mark Erfe Outcomes of Sutureless/Rapid Deployment Valves Compared to Traditional Bioprosthetic Aortic Valves The Annals of Thoracic Surgery September 2020 J.
Hunter Mehaffey 1 Aortic Annular Enlargement in the Elderly: Short and Long-Term Outcomes in the United States The Annals of Thoracic Surgery January 2021 Shinichi Fukuhara 2 Surgical Explant of Transcatheter Aortic Bioprosthesis: Results and Clinical Implications from The Society of Thoracic Surgeons Adult Cardiac Database Analysis Circulation December (..)
They adjusted for the participants' use of tobacco and other characteristics, including their age, sex, race, body mass index or BMI, obesity, diabetes, physical activity levels, and socioeconomic status. For a more complete funding disclosure and list of authors, please see the full JAHA research article.
She is one of the first fellowship-trained obesity medicine physicians in the world. Centers for Disease Control and Prevention and as a behavioral sciences intern at the American Cancer Society. She researches strategies to treat diabetes mellitus and reduce the risk of cardiovascular, renal, and other diabetes-related complications.
In the Sunday Times of April 23 rd , 2017, this article appeared, entitled ‘ Kellogg’s smothers health crisis in sugar – The cereals giant is funding studies that undermine official warnings on obesity.’ The study, published in the Journal Obesity Facts relied on evidence from 14 studies. Just to choose a few paragraphs. ‘
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content